These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


132 related items for PubMed ID: 8199770

  • 1. Flecainide: its value and danger.
    Malik R, Ellenbogen KA, Stambler BS, Wood MA.
    Heart Dis Stroke; 1994; 3(2):85-9. PubMed ID: 8199770
    [Abstract] [Full Text] [Related]

  • 2. [Flecainide and anti-arrhythmia therapy].
    Croce L, Romano S, Pozzoni L, Lomuscio A.
    Minerva Med; 1988 Mar; 79(3):229-34. PubMed ID: 3129677
    [Abstract] [Full Text] [Related]

  • 3. Flecainide acetate for the treatment of atrial and ventricular arrhythmias.
    Apostolakis S, Oeff M, Tebbe U, Fabritz L, Breithardt G, Kirchhof P.
    Expert Opin Pharmacother; 2013 Feb; 14(3):347-57. PubMed ID: 23294160
    [Abstract] [Full Text] [Related]

  • 4. Flecainide for supraventricular tachyarrhythmias.
    Med Lett Drugs Ther; 1992 Jul 24; 34(875):71-2. PubMed ID: 1630411
    [No Abstract] [Full Text] [Related]

  • 5. Meta-analysis of flecainide safety in patients with supraventricular arrhythmias.
    Wehling M.
    Arzneimittelforschung; 2002 Jul 24; 52(7):507-14. PubMed ID: 12189773
    [Abstract] [Full Text] [Related]

  • 6. Flecainide as first-line treatment for supraventricular tachycardia in newborns.
    Ferlini M, Colli AM, Bonanomi C, Salvini L, Galli MA, Salice P, Ravaglia R, Centola M, Danzi GB.
    J Cardiovasc Med (Hagerstown); 2009 May 24; 10(5):372-5. PubMed ID: 19300276
    [Abstract] [Full Text] [Related]

  • 7. Encainide hydrochloride and flecainide acetate: two class 1c antiarrhythmic agents.
    Chase SL, Sloskey GE.
    Clin Pharm; 1987 Nov 24; 6(11):839-50. PubMed ID: 3119276
    [Abstract] [Full Text] [Related]

  • 8. Flecainide: a new antiarrhythmic agent.
    Nestico PF, Morganroth J.
    Am Fam Physician; 1986 Nov 24; 34(5):197-200. PubMed ID: 2430440
    [No Abstract] [Full Text] [Related]

  • 9. Flecainide toxicity in a neonate with supraventricular tachycardia.
    Zeigler VL, Peterson J.
    Heart Lung; 1991 Nov 24; 20(6):689-91. PubMed ID: 1960074
    [Abstract] [Full Text] [Related]

  • 10. Treatment of refractory supraventricular arrhythmias with flecainide acetate.
    Till JA, Rowland E, Shinebourne EA, Ward DE.
    Arch Dis Child; 1987 Mar 24; 62(3):247-52. PubMed ID: 3105471
    [Abstract] [Full Text] [Related]

  • 11. Fetal and maternal magnetocardiography during flecainide therapy for supraventricular tachycardia.
    Campbell JQ, Best TH, Eswaran H, Lowery CL.
    Obstet Gynecol; 2006 Sep 24; 108(3 Pt 2):767-71. PubMed ID: 17018496
    [Abstract] [Full Text] [Related]

  • 12. [Life-threatening ventricular tachycardia during flecainide treatment for symptomatic atrial fibrillation in a patient with a structural cardiac disorder].
    Rienstra M, Wiesfeld AC, van Veldhuisen DJ, van Gelder IC.
    Ned Tijdschr Geneeskd; 2006 May 06; 150(18):1027-31. PubMed ID: 16715868
    [Abstract] [Full Text] [Related]

  • 13. Neonatal flecainide toxicity following supraventricular tachycardia treatment.
    Hall CM, Ward Platt MP.
    Ann Pharmacother; 2003 Sep 06; 37(9):1343-4. PubMed ID: 12921523
    [No Abstract] [Full Text] [Related]

  • 14. [Flecainide and paroxysmal supraventricular tachycardia in the operating room].
    Borgeat A, Thorin D.
    Schweiz Med Wochenschr; 1988 Jun 18; 118(24):944-6. PubMed ID: 3135590
    [Abstract] [Full Text] [Related]

  • 15. Guidelines for the use of flecainide in patients with supraventricular arrhythmias.
    Smith W, Crozier I, McAlister H, O'Meeghan T, Stewart F.
    N Z Med J; 2000 Oct 13; 113(1119):420-1. PubMed ID: 11127360
    [No Abstract] [Full Text] [Related]

  • 16. [Propafenone and flecainide in the therapy of ventricular arrhythmias].
    Paperini L, Davini A, Lattanzi F, Topi A, Reisenhofer B, Squarcini G, Paci A, Topi PL.
    Minerva Cardioangiol; 1995 Oct 13; 43(10):449-57. PubMed ID: 8819814
    [Abstract] [Full Text] [Related]

  • 17. Safety and efficacy of oral flecainide acetate in patients with cardiac arrhythmias.
    Nakazato Y, Nakata Y, Yasuda M, Nakazato K, Sumiyoshi M, Ogura S, Yamaguchi H.
    Jpn Heart J; 1997 May 13; 38(3):379-85. PubMed ID: 9290572
    [Abstract] [Full Text] [Related]

  • 18. International Symposium on Supraventricular Arrhythmias: Focus on Flecainide. October 23-26, 1987, Paradise Island, Nassau, Bahamas. Proceedings.
    Am J Cardiol; 1988 Aug 25; 62(6):1D-67D. PubMed ID: 3136629
    [No Abstract] [Full Text] [Related]

  • 19. Flecainide acetate in the treatment of resistant supraventricular arrhythmias.
    Epstein M, Jardine RM, Obel IW.
    S Afr Med J; 1988 Dec 03; 74(11):559-62. PubMed ID: 3143159
    [Abstract] [Full Text] [Related]

  • 20. Dangerous recurrence of arrhythmia following withdrawal of flecainide.
    Murdoch IA, Priestley KA, Parsons JM.
    Int J Cardiol; 1990 Aug 03; 28(2):259-60. PubMed ID: 2118487
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.